Testing for leukemia in adults typically starts with a simple blood draw and, if results are abnormal, progresses through a series of increasingly specialized tests over days to weeks. The process follows a logical sequence: screening blood work first, then microscopic examination, bone marrow sampling, and finally genetic analysis that identifies the exact type of leukemia and guides treatment.
The Complete Blood Count Comes First
A complete blood count (CBC) is almost always the first test ordered when leukemia is suspected. It measures three key cell populations in your blood: red blood cells, white blood cells, and platelets. Normal white blood cell counts in adults fall between 3.4 and 9.6 billion cells per liter. In leukemia, that number can be dramatically high or unusually low, depending on the type.
Red blood cell counts and platelet counts matter too. Leukemia crowds out normal blood cell production in the bone marrow, so many people show up with low red blood cells (anemia) and low platelets at the same time their white blood cell count is abnormal. A CBC alone cannot diagnose leukemia, but it raises the red flag that triggers everything else. Results typically come back the same day.
Blood Smear: Looking at Cells Under a Microscope
If the CBC is abnormal, a lab technician spreads a thin layer of your blood on a glass slide and examines it under a microscope. This peripheral blood smear reveals the shape, size, and maturity of individual cells. The key finding is the presence of blast cells, which are immature blood cells that normally stay inside bone marrow. Healthy blood contains very few blasts. When blasts make up 20% or more of the cells in your blood, that’s a hallmark sign of acute leukemia.
The smear also helps distinguish between types. Certain leukemias produce cells with distinctive features visible under magnification, giving doctors an early clue about what they’re dealing with before more advanced tests come back.
Bone Marrow Biopsy: The Definitive Test
A bone marrow biopsy is the most important single test in a leukemia diagnosis. It provides a direct sample from the factory where blood cells are made, giving a much clearer picture than blood alone.
The procedure involves two parts, usually done back to back. First, the aspiration: a hollow needle is inserted through bone into the marrow, and a syringe draws out a liquid sample. Then the biopsy: a slightly larger needle extracts a small cylindrical core of solid marrow tissue. Both samples typically come from the back of the hip bone (the posterior iliac crest), though occasionally the front of the hip is used instead.
You lie on your stomach or side during the procedure. The area is numbed with local anesthetic, and the whole process takes about 15 to 30 minutes. Most people describe a deep pressure sensation and a brief, sharp pulling feeling when the marrow is drawn out. Afterward, pressure is applied to stop bleeding and the site is bandaged. Soreness at the biopsy site can last a few days.
The marrow samples are then divided up and sent for several different analyses, each answering a different question about the disease.
Flow Cytometry: Identifying the Cell Type
Flow cytometry is a lab technique that identifies exactly what kind of cells are in your blood or marrow sample. It works by tagging cells with fluorescent markers that attach to specific proteins on the cell surface, then passing those cells through a laser one by one. The pattern of proteins tells doctors whether the leukemia involves B cells, T cells, or myeloid cells, which is essential for classifying the disease and choosing treatment.
For example, B-cell leukemias typically display certain surface proteins (CD19 and CD10, among others), while T-cell leukemias carry a different set (CD3, CD7, CD5). Sometimes leukemia cells express an unusual mix of markers from different cell lineages, which flow cytometry can detect. Results come back within 24 to 48 hours, making this one of the faster specialized tests.
Genetic and Chromosomal Testing
Leukemia is driven by specific genetic mutations and chromosomal rearrangements, and identifying them has become a critical part of diagnosis. Two main types of genetic testing are used.
Cytogenetic Analysis
This test examines the chromosomes inside leukemia cells, looking for pieces that have broken off and reattached in the wrong place. The most well-known example is the Philadelphia chromosome, found in nearly all cases of chronic myeloid leukemia (CML), where parts of chromosomes 9 and 22 swap places. Another common rearrangement, a swap between chromosomes 8 and 21, appears in about 10% of acute myeloid leukemia cases and is so characteristic that it can confirm an AML diagnosis even when blast counts are below the usual 20% threshold. Cytogenetic results typically take one to two weeks because the lab needs to grow cells in culture before examining them.
Next-Generation Sequencing
Molecular testing goes deeper, reading the DNA of leukemia cells to find specific gene mutations. Standard panels screen for mutations in genes like FLT3, NPM1, IDH1, IDH2, JAK2, TP53, and others. These mutations don’t just confirm the diagnosis. They predict how aggressive the leukemia is and whether certain targeted therapies will work. NGS panels average about 10 days for results, sometimes extending to 14 days. Individual molecular tests for single genes can come back in one to two days.
Physical Exam and Imaging
Before or alongside lab work, doctors perform a physical examination looking for signs that leukemia has affected other organs. An enlarged spleen is the most common physical finding, particularly in CML, where more than half of patients have a spleen that extends well beyond its normal borders at the time of diagnosis. The size of the spleen tends to correlate with how high the white blood cell count is. Doctors also feel for enlarged lymph nodes and check for an enlarged liver.
Skin findings can offer clues as well. Petechiae (tiny red dots from broken blood vessels) and easy bruising suggest that platelet counts are dangerously low, which can happen when leukemia takes over the marrow. In rare cases with extremely high white blood cell counts (above 300,000 to 600,000 cells per microliter), an eye exam can reveal swollen optic nerves and retinal hemorrhages caused by blood that has become too thick to flow normally.
CT scans or ultrasounds may be ordered to measure organ enlargement more precisely or to check for swollen lymph nodes deep inside the body that can’t be felt on exam.
Spinal Fluid Testing for Some Types
Not every leukemia patient needs a lumbar puncture (spinal tap), but it’s a routine part of the workup for acute lymphoblastic leukemia (ALL). ALL has a tendency to spread to the central nervous system, so doctors collect a small sample of cerebrospinal fluid to check for leukemia cells in the brain and spinal cord. This test also serves double duty: during the same procedure, chemotherapy can be delivered directly into the spinal fluid as a preventive measure.
How Long the Full Workup Takes
The timeline depends on the type of leukemia suspected. For acute leukemia, where treatment needs to start quickly, initial blood work and a blood smear can happen within hours. A bone marrow biopsy is often performed within the first day or two. Flow cytometry results follow in 24 to 48 hours, giving doctors enough information to begin treatment while waiting for genetic results.
The slowest piece is next-generation sequencing, which takes 10 to 14 days. This means you may already be in treatment before your complete genetic profile comes back. Doctors sometimes adjust the treatment plan once those results arrive, particularly if the sequencing reveals mutations that respond to targeted drugs.
For chronic leukemias, which progress more slowly, the diagnostic process can unfold over days to weeks without the same urgency. Some cases of chronic lymphocytic leukemia (CLL) are even discovered incidentally during routine blood work, when a CBC shows an unexpectedly high white blood cell count in someone who feels perfectly fine.